Amalgamated Bank’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-805
Closed -$14K 2012
2025
Q4
$14K Sell
805
-71
-8% -$1.25K ﹤0.01% 2275
2025
Q3
$19K Hold
876
﹤0.01% 2145
2025
Q2
$12K Buy
+876
New +$13.8K ﹤0.01% 2351

Other funds holding ETON

Amalgamated Bank's ETON Position: Q1 2026 in Review

Amalgamated Bank sold out of Eton Pharmaceutcials (ETON) in Q1 2026, closing a stake of 805 shares — an estimated $14K sold.

Amalgamated Bank first reported a position in ETON in Q2 2025 and held it in 3 quarters. The position peaked at $19K in Q3 2025. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Amalgamated Bank reported no remaining Eton Pharmaceutcials position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 805 Eton Pharmaceutcials shares in Q1 2026, an estimated $14K.
  • Amalgamated Bank first reported a position in Eton Pharmaceutcials in Q2 2025 and held it in 3 quarters.
  • Amalgamated Bank's Eton Pharmaceutcials position peaked at $19K in Q3 2025.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.